Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Cyril Seroussi"'
Autor:
Grit Andersen, Rosy Eloy, Susanne Famulla, Tim Heise, Grégory Meiffren, Cyril Seroussi, Martin Gaudier, Claire Mégret, You‐Ping Chan, Olivier Soula, Matthew Riddle
Publikováno v:
Diabetes, Obesity and Metabolism. 25
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::19096cf36cfed1bbfac2360c65466891
https://doi.org/10.1111/dom.15067
https://doi.org/10.1111/dom.15067
Autor:
null Grit Andersen, null Rosy Eloy, null Susanne Famulla, null Tim Heise, null Grégory Meiffren, null Cyril Seroussi, null Martin Gaudier, null Claire Mégret, null You‐Ping Chan, null Olivier Soula, null Matthew Riddle
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8ed92bd5dfed53094ecd117ff0d8208e
https://doi.org/10.1111/dom.14972/v2/response1
https://doi.org/10.1111/dom.14972/v2/response1
Autor:
Claire Mégret, You-Ping Chan, Rosy Eloy, Grit Andersen, J. Hans DeVries, Grégory Meiffren, Olivier Soula, Martin Gaudier, Cyril Seroussi, Tim Heise, Susanne Famulla
Publikováno v:
Diabetes. 70
ADO09 is a co-formulation of Pram and insulin A21G developed to deliver the positive effects of Pram without additional injections. This double-blind randomized cross-over trial investigated the effects of pre-meal ADO09 vs. insulin aspart (ASP) on m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::344b58e8f9605e9d2046b5ae4726d3b5
https://doi.org/10.2337/db21-197-or
https://doi.org/10.2337/db21-197-or
Autor:
Aymeric Ranson, Jorge Arrubla, Bruce W. Bode, Grégory Meiffren, Olivier Soula, Martin Gaudier, Cyril Seroussi, José Correia, Bertrand Alluis, Oliver Klein, Rémi Soula, Tim Heise, J. Hans DeVries
Publikováno v:
Diabetes, Obesity and Metabolism. 21:1066-1070
We investigated the pharmacodynamics (PD) and pharmacokinetics (PK) of BioChaperone insulin Lispro (BCLIS), faster insulin aspart (FIA) and insulin aspart (ASP) in patients with type 1 diabetes using an insulin pump. In this randomized, double-blind,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b93e4bd3b85e1c76537a1b94e6a00f8
https://doi.org/10.1111/dom.13621
https://doi.org/10.1111/dom.13621
Autor:
Grit Andersen, Grégory Meiffren, Susanne Famulla, Tim Heise, Aymeric Ranson, Cyril Seroussi, Rosy Eloy, Martin Gaudier, Richard Charvet, You‐Ping Chan, Olivier Soula, J. Hans DeVries
Publikováno v:
Diabetes, Obesity and Metabolism. 23
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::09dbf8fcd5c4721ef0ea23873b3b6cee
https://doi.org/10.1111/dom.14378
https://doi.org/10.1111/dom.14378
Autor:
Grégory Meiffren, Grit Andersen, J. Hans DeVries, Olivier Soula, Susanne Famulla, Richard Charvet, Martin Gaudier, Tim Heise, Aymeric Ranson, Rosy Eloy, You-Ping Chan, Cyril Seroussi
Publikováno v:
Diabetes, obesity & metabolism, 23(4), 961-970. Wiley-Blackwell
Aim: To compare the safety, pharmacokinetics and pharmacodynamics of ADO09 with insulin lispro (Lispro) and separate subcutaneous injections of human insulin and pramlintide (Ins&Pram) in 24 subjects with type 1 diabetes. Methods: At three dosing vis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7bd276e57e5cbc9a4303b6b2f02c80d
https://pubmed.ncbi.nlm.nih.gov/33336850
https://pubmed.ncbi.nlm.nih.gov/33336850
Autor:
Martin Gaudier, Susanne Famulla, Cyril Seroussi, Rosy Eloy, Grégory Meiffren, Grit Andersen, Richard Charvet, Olivier Soula, Tim Heise, J. Hans DeVries, Aymeric Ranson, You-Ping Chan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::53b092835fde852201dee76db3559eee
https://doi.org/10.1111/dom.14302/v2/response1
https://doi.org/10.1111/dom.14302/v2/response1
Autor:
Tim Heise, J. Hans DeVries, Claire Mégret, Grégory Meiffren, Martin Gaudier, Rosy Eloy, Cyril Seroussi, Olivier Soula, Susanne Famulla, You-Ping Chan, Grit Andersen
Publikováno v:
Diabetes. 69
ADO09 is a co-formulation of PRAM and insulin A21G developed to leverage the beneficial effects of PRAM on post-prandial glucose without additional injections. This double-blind randomized cross-over trial studied pre-meal ADO09 vs. Novolog® over 24
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2c6f5a95073baba46b671a1331666759
https://doi.org/10.2337/db20-112-lb
https://doi.org/10.2337/db20-112-lb
Autor:
Aymeric Ranson, Martin Gaudier, Cyril Seroussi, Tim Heise, Bertrand Alluis, J. Hans DeVries, Grit Andersen, Grégory Meiffren, Olivier Soula, Daniela Lamers
Publikováno v:
Diabetes, obesity & metabolism, 20(11), 2627-2632. Wiley-Blackwell
Aim To investigate the safety and efficacy of BioChaperone Lispo (BCLIS), an ultra-rapid formulation of insulin lispro (LIS) in people with type 1 diabetes. Materials and methods In this randomized, double-blind study, participants self-administered
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a52850006e4ff4297552d935246edd84
https://doi.org/10.1111/dom.13442
https://doi.org/10.1111/dom.13442
Autor:
J. Hans DeVries, Aymeric Ranson, Tim Heise, Martin Gaudier, Rémi Soula, Cyril Seroussi, Eric Zijlstra, Richard Charvet, Grégory Meiffren, Olivier Soula, Grit Andersen
Publikováno v:
Diabetes. 68
BCPramIns is developed to leverage the beneficial effects of PRAM on post-prandial BG control in a convenient co-formulation with INS. This double-blind, randomized cross-over study investigated pharmacodynamics, pharmacokinetics and safety of BCPram
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::081f8f27e54eb174ad440183481fd877
https://doi.org/10.2337/db19-150-or
https://doi.org/10.2337/db19-150-or